当前位置:首页 - 行情中心 - 大唐药业(920433) - 财务分析

大唐药业

(920433)

  

流通市值:9.31亿  总市值:14.08亿
流通股本:1.69亿   总股本:2.56亿

大唐药业(920433)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.02亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益37967.64万元,未分配利润-3856.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产54769.45万元,负债16801.81万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入42,981,295.49133,403,704.17102,317,249.573,858,902.06
营业总成本39,737,876.88213,454,416.1150,712,037.9999,538,721.68
其他经营收益
营业利润2,801,863.36-86,278,562.3-47,943,695.23-25,510,115.49
利润总额2,801,863.36-86,781,628.75-47,476,089.27-25,263,615.49
净利润2,389,587.39-83,188,081.18-41,077,170.17-21,901,231.33
每股收益
其他综合收益----
综合收益总额2,389,587.39-83,188,081.18-41,077,170.17-21,901,231.33
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计156,118,065.35140,149,409.37163,241,529.41178,883,252.11
非流动资产:
非流动资产合计391,576,441.71403,764,465.55418,068,512.09420,967,017.45
资产总计547,694,507.06543,913,874.92581,310,041.5599,850,269.56
流动负债:
流动负债合计148,972,690.12144,502,823.92138,518,464.86137,351,544.43
非流动负债:
非流动负债合计19,045,385.3219,551,064.720,820,679.3321,353,230.53
负债合计168,018,075.44164,053,888.62159,339,144.19158,704,774.96
所有者权益(或股东权益):
归属于母公司股东权益合计379,676,431.62379,859,986.3421,970,897.31441,145,494.6
股东权益合计379,676,431.62379,859,986.3421,970,897.31441,145,494.6
负债和股东权益合计547,694,507.06543,913,874.92581,310,041.5599,850,269.56
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计34,352,442.22163,207,662.25133,502,751.6994,832,724.9
经营活动现金流出小计36,388,729.45176,606,230138,916,885.193,335,927.7
经营活动产生的现金流量净额-2,036,287.23-13,398,567.75-5,414,133.411,496,797.2
投资活动产生的现金流量:
投资活动现金流入小计-163,356,129.07122,162,964.0684,987,142.03
投资活动现金流出小计631,241.87136,654,749.44112,086,925.5879,097,448.81
投资活动产生的现金流量净额-631,241.8726,701,379.6310,076,038.485,889,693.22
筹资活动产生的现金流量:
筹资活动现金流入小计23,450,543.7287,812,653.167,520,870.9340,979,690.94
筹资活动现金流出小计10,551,399.83113,326,356.7584,080,663.0866,208,588.5
筹资活动产生的现金流量净额12,899,143.89-25,513,703.65-16,559,792.15-25,228,897.56
汇率变动对现金及现金等价物的影响919.49-1,351.87-702.15424.98
现金及现金等价物净增加额10,232,534.28-12,212,243.64-11,898,589.23-17,841,982.16
期末现金及现金等价物余额29,712,104.1219,479,569.8419,793,224.2513,849,831.32
补充资料:
现金及现金等价物的净增加额--12,212,243.64--17,841,982.16
TOP↑